14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CANF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Can-Fite BioPharma Ltd stock price after Friday trading.
(Updated on May 03, 2024)

Hold candidate since May 03, 2024 PDF

The Can-Fite BioPharma Ltd stock price gained 2.96% on the last trading day (Friday, 3rd May 2024), rising from $2.03 to $2.09. During the last trading day the stock fluctuated 6.44% from a day low at $2.02 to a day high of $2.15. The price has fallen in 5 of the last 10 days but is still up by 5.56% over the past 2 weeks. Volume fell on the last day by -8 thousand shares and in total, 3 thousand shares were bought and sold for approximately $6.31 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Can-Fite BioPharma Ltd stock with a 90% probability to be traded between $1.93 and $2.41 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CANF Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 8.85%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Can-Fite BioPharma Ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.14. On a fall, the stock will find some support from the short-term average at $2.02. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Can-Fite BioPharma Ltd stock

Can-Fite BioPharma Ltd finds support from accumulated volume at $2.08 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.130 between high and low, or 6.44%. For the last week the stock has had daily average volatility of 7.41%.

Our recommended stop-loss: $2.02 (-3.46%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (CANF) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Can-Fite BioPharma Ltd to open at $2.09, and during the day (based on 14 day Average True Range), to move between $1.95 and $2.23, which gives a possible trading interval of +/-$0.136 (+/-6.53%) up or down from last closing price. If Can-Fite BioPharma Ltd takes out the full calculated possible swing range there will be an estimated 13.05% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.08 (0.47%) than the resistance at $2.10 (0.48%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Can-Fite BioPharma Ltd stock A Buy?

Can-Fite BioPharma Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.634 Hold/Accumulate Upgraded

Predicted Opening Price for Can-Fite BioPharma Ltd of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$2.09 ( 0.159%) $2.09

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CANF

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.22 6.06 %
R2 2.17 3.68 %
R1 2.14 2.22 %
Current price: 2.09
Support S1 2.04 -2.54 %
S2 2.01 -4.00 %
S3 1.96 -6.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.35 12.44 %
R2 2.31 10.53 %
R1 2.10 0.478 %
Current price 2.09
Support S1 2.08 -0.474%
S2 2.07 -0.96%
S3 2.06 -1.44%

FAQ

What is the symbol for Can-Fite BioPharma Ltd Stock and on which exchange is it traded?
The symbol for Can-Fite BioPharma Ltd is CANF and it is traded on the NYSEMKT (NYSE American).

Should I buy or sell Can-Fite BioPharma Ltd Stock?
Can-Fite BioPharma Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Can-Fite BioPharma Ltd Stock?
Can-Fite BioPharma Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Can-Fite BioPharma Ltd Stock.

What's the current price of Can-Fite BioPharma Ltd Stock?
As of the end of day on the May 03, 2024, the price of an Can-Fite BioPharma Ltd (CANF) share was $2.09.

What is the 52-week high and low for Can-Fite BioPharma Ltd Stock?
The 52-week high for Can-Fite BioPharma Ltd Stock is $3.33 and the 52-week low is $1.81.

What is the market capitalization of Can-Fite BioPharma Ltd Stock?
As of the May 03, 2024, the market capitalization of Can-Fite BioPharma Ltd is 11.457M.

When is the next earnings date for Can-Fite BioPharma Ltd?
The upcoming earnings date for Can-Fite BioPharma Ltd is Jun 06, 2024.
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT